Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01187160 · ClinicalTrials.gov registry record · NA

Transoral Robotic Surgery (TORS) for Sleep Apnea

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
154
Enrollment target

NCT01187160: Completed NA study, sponsored by University of Pennsylvania.

NCT01187160 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 154 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01187160, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target

Study Summary

The purpose of this study is to assess if the da Vinci® Robotic Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA) allows for "adequate exposure" for transoral resection of hypertrophic lingual tonsils in patients with obstructive sleep apnea.

Interventions

  • PROCEDURE Transoral robotic surgery (TORS)

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2009-10
Est. Completion 2014-11
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT01187160 record still lists

NCT01187160 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Transoral robotic surgery (TORS) is the first listed.

NCT01187160 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01187160 about?

NCT01187160 is a clinical study titled "Transoral Robotic Surgery (TORS) for Sleep Apnea". The purpose of this study is to assess if the da Vinci® Robotic Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA) allows for "adequate exposure" for transoral resection of hypertrophic lingual tonsils in patients with obstructive sleep apnea.

What is the current status of trial NCT01187160?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2009-10. Estimated completion is 2014-11.

What interventions are being tested in trial NCT01187160?

The interventions under investigation include: Transoral robotic surgery (TORS) (PROCEDURE).

Who is sponsoring clinical trial NCT01187160?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01187160's enrollment target sits among peer trials

154 656th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01187160, the US trial registry maintained by the National Library of Medicine. NCT01187160 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.